Stocktoria
Cellebrite DI Ltd. CLBT
Nasdaq · XNAS · stock · Services-Prepackaged Software · website · IPO 2021-08-31
Cellebrite DI Ltd. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 84.2% | 84.4% | 83.6% | 81.3% | 82.7% |
| Operating margin | 14.0% | 14.2% | 10.2% | 0.4% | 5.6% |
| Net margin | 16.5% | -70.5% | -24.9% | 44.6% | 29.0% |
| FCF margin | 33.7% | 30.8% | 29.8% | 5.1% | 12.6% |
| Return on assets | 8.3% | -41.0% | -15.2% | 30.0% | 21.0% |
| Return on equity | 16.2% | -84.2% | -237.1% | 163.5% | -97.3% |
| Current ratio | 1.56 | 1.92 | 1.66 | 1.42 | 1.46 |
| Revenue growth | 18.6% | 23.4% | 20.1% | 9.9% | 26.3% |
Source: SEC EDGAR filings · CIK 0001854587 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.